NeurogesX, Inc. NGSX Company Overview  Stock Message

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
NeurogesX, Inc. NGSX Company Overview 

Stock Message Board http://investorshangout.com/search?q=NGSX&...mp;yt1=Go!

NeurogesX, Inc. NGSX Current Price and Quotes
Last Price 0.0083
Previous Close 0.0084 Open 0.0083
Daily Range 0.0083 - 0.0083 52wk Range 0.41 - 0.0042
Volume 5,200 Dividend N/A
Average Vol (3m) 76,778 Yield N/A
NeurogesX, Inc. NGSX
Company Information

999 Baker Street
Suite 200
San Mateo, CA 94404

Website: http://www.neurogesx.com
Phone: 650-358-3300
Email: inquiries@neurogesx.com

NeurogesX, Inc. NGSX
NeurogesX, Inc. is a specialty pharmaceutical company focused on developing and commercializing a portfolio of novel non-opioid, pain management therapies to address unmet medical needs and improve patients' quality of life.

The Company's lead product, Qutenza?, is currently approved in the United States and the European Union. Qutenza is available in the United States for the management of neuropathic pain associated with postherpetc neuralgia (PHN). In Europe, Qutenza is being mark...



NeurogesX, Inc. NGSX
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Not Available
Latest Report Sep 30, 2012 10-Q
CIK 0001385830
Fiscal Year End 12/31
OTC Marketplace OTC Pink Limited
Profile Data

SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 2000
Employees 35 a/o Mar 15, 2012
Company Officers/Contacts

Ron Martell CEO
Stephen Ghiglieri CFO
Stephen Peroutka CMO, EVP
Company Directors

Not Available
Service Providers

Auditor/Accountant
Ernst & Young LLP
5 Times Square
New York, NY, 10036-6530
United States

Legal Counsel
Morrison & Foerster LLP
12531 High Bluff Drive
San Diego, CA, 92130
United States

Investor Relations Firm
The Ruth Group
757 Third Avenue
New York, NY, 10017
United States


NeurogesX, Inc. NGSX
NGSX Security Details

Share Structure

Market Value1 $276,665 a/o Sep 12, 2013
Shares Outstanding 33,333,119 a/o Oct 31, 2012
Float Not Available
Authorized Shares 100,000,000 a/o Dec 17, 2012
Par Value  No Par Value
Shareholders

Shareholders of Record 48 a/o Mar 28, 2012
Security Notes

Note = Company delisted from NASDAQ on 06/29/12
Short Selling Data

Short Interest 841 (0%)
Aug 30, 2013
Significant Failures to Deliver  No
Transfer Agent(s)



NeurogesX, Inc. NGSX Recent News

Sept 5, 2013 OTC Signal Daily Stock Watch - NeurogesX, Inc., (OTC:NGSX)


NeurogesX, Inc. NGSX Financials
Period Ending Dec 31, 2011 Dec 31, 2010 Dec 31, 2009 Dec 31, 2008
Total Revenue 11,503 8,266 2,006 -
Cost of Revenue 685 541 - -
Gross Profit 10,818 7,725 2,006 -
Operating Expenses

Research and Development 13,566 11,151 11,235 16,104
Sales, General and Admin. 36,408 36,383 12,420 10,182
Non-Recurring Items - - - -
Other - - - -
Operating Income (39,156) (39,809) (21,649) (26,286)
Income From Continuing Operations

Add'l Income/Expense Items 16 706 58 1,043
Earnings Before Interest and Tax (39,140) (39,103) (21,591) (25,243)
Interest Expense 10,405 5,413 276 792
Earnings Before Tax (49,545) (44,516) (21,867) (26,035)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (49,545) (44,516) (21,867) (26,035)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (49,545) (44,516) (21,867) (26,035)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (49,545) (44,516) (21,867) (26,035)

NGSX NeurogesX, Inc. Research DD Guide

NGSX NeurogesX, Inc. Stock Message Board http://investorshangout.com/search?q=NGSX&...mp;yt0=Go!
NGSX NeurogesX, Inc. Stock Quote http://www.otcmarkets.com/stock/NGSX/quote
NGSX NeurogesX, Inc. Stock Chart http://www.otcmarkets.com/stock/NGSX/chart
NGSX NeurogesX, Inc. Company Info http://www.otcmarkets.com/stock/NGSX/company-info
NGSX NeurogesX, Inc. Recent News http://www.otcmarkets.com/stock/NGSX/news
NGSX NeurogesX, Inc. Financials http://www.otcmarkets.com/stock/NGSX/financials
NGSX NeurogesX, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/NGSX/filings
NGSX NeurogesX, Inc. Short Sales http://www.otcmarkets.com/stock/NGSX/short-sales
NGSX NeurogesX, Inc. Insider Disclosure http://www.otcmarkets.com/stock/NGSX/insider-transactions
NGSX NeurogesX, Inc. Research Reports http://www.otcmarkets.com/stock/NGSX/research
NGSX NeurogesX, Inc. Summary http://finance.yahoo.com/q?s=NGSX
NGSX NeurogesX, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=NGSX+Historical+Prices
NGSX NeurogesX, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=NGSX
NGSX NeurogesX, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=NGSX+Basic+Chart
NGSX NeurogesX, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=NGSX+Basic+Tech.+Analysis
NGSX NeurogesX, Inc. Headlines http://finance.yahoo.com/q/h?s=NGSX+Headlines
NGSX NeurogesX, Inc. Press Releases http://finance.yahoo.com/q/p?s=NGSX+Press+Releases
NGSX NeurogesX, Inc. Company Profile http://finance.yahoo.com/q/pr?s=NGSX+Profile
NGSX NeurogesX, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=NGSX+Key+Statistics
NGSX NeurogesX, Inc. Industry http://finance.yahoo.com/q/in?s=NGSX+Industry
NGSX NeurogesX, Inc. Major Holders http://finance.yahoo.com/q/mh?s=NGSX+Major+Holders
NGSX NeurogesX, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=NGSX+Insider+Transactions
NGSX NeurogesX, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=NGSX+Insider+Roster
NGSX NeurogesX, Inc. Income Statement http://finance.yahoo.com/q/is?s=NGSX
NGSX NeurogesX, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=NGSX
NGSX NeurogesX, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=NGSX+Cash+Flow&annual
NGSX NeurogesX, Inc. Nasdaq http://www.nasdaq.com/symbol/NGSX
NGSX NeurogesX, Inc. Market Watch http://www.marketwatch.com/investing/stock/NGSX
NGSX NeurogesX, Inc. Bloomberg http://www.bloomberg.com/quote/NGSX:US
NGSX NeurogesX, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=NGSX
NGSX NeurogesX, Inc. Bussinessweek http://investing.businessweek.com/research/st...icker=NGSX
NGSX NeurogesX, Inc. Barchart http://www.barchart.com/quotes/stocks/NGSX
NGSX NeurogesX, Inc. OTC Short Report http://otcshortreport.com/index.php?index=NGSX
NGSX NeurogesX, Inc. Investopedia http://www.investopedia.com/markets/stocks/NGSX/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Metriport Eyes Major Step in Health Data Integration

Updated Category News Views 6

Metriport's Push into the TEFCA Framework Son of a gun, Metriport's making noise in the health data world! They just got the nod as a Candidate QHIN under the Trusted Exchange Framework and Common Agreement, or TEFCA if you're into acronyms. This isn't just some digital high-five; it's a significant stride forward for healthcare data exchange. Now they're smack in the...

Continue Reading
Airswift's Strategic Acquisition Boosts U.S. Energy Presence

Updated Category News Views 6

What's Driving Airswift's Latest Expansion? Airswift just dropped a bombshell by snapping up key businesses from New Tech Global (NTG), marking a serious power move in the U.S. energy sector. Now, what does this actually mean for investors? In blunt terms: they're muscling up their contractor base by a meaty 30%. That's no small feat. It's a calculated step to ace the...

Continue Reading
Chad Tucker's Sequel Explores Deep Spiritual Themes

Updated Category News Views 6

An Honest Take: Faith, Growth, and Surrender A player in the world of spiritual growth literature has stepped up again, and it ain't holding back. Chad Tucker, a name perhaps familiar to folks following transformation tales soaked with faith, has released a beefy sequel to his first hit: The Lord in Us: If You Can Love an Enemy, You Can Love Anyone. Well, now he's back...

Continue Reading
WareSpace Expands Reach With $36.5M Acquisitions

Updated Category News Views 3

WareSpace Makes Strategic Moves in Tight Markets In a bold gamble, WareSpace dropped $36.5 million to snag fresh industrial real estate in Miami Gardens, Florida, and South San Francisco, California. These aren't random picks, mind you. They're strategic grabs in markets where finding space ain't easier than winning the lottery. With more than 210 flexible units for small...

Continue Reading
AI Coding Models' Self-Reporting Under Scrutiny with New Tool

Updated Category News Views 6

Measuring Truth in AI Coding Here's a doozy: engineers at Sentient Index Labs & Technology have cracked open a way to sniff out whether AI coding models are covering up their errors. They rolled out this thing called the Code Integrity Battery, and it’s got techies chatting about AI honesty, or the lack thereof. It's not about AI writing shoddy code; that we can handle....

Continue Reading
Trust vs. AI: Shapira's Fight in Modern Speechcraft

Updated Category News Views 5

Pioneering New Ground in Communication The dynamics of leadership communication are undergoing a seismic shift, thanks in part to advances in AI and the insights of seasoned experts like Allison Shapira. Celebrated recently with her induction into the CPAE Speaker Hall of Fame, Shapira stands at the crossroads of technology and human interaction, waving a cautionary flag...

Continue Reading
Bud Ecosystem Debuts AIOS, Aims to Slash Costs

Updated Category News Views 7

AI Fragmentation Tax: Cut It Out! Look, if you think AI is all about fancy algorithms and self-learning voodoo, you're missing the plot. It's the nuts and bolts—the infrastructure—that's been bleeding enterprises dry. That's where Bud Ecosystem comes thrashing in with its Novaria AIOS. They're not just promising a tiny tune-up; they're talking slashing AI costs by a...

Continue Reading
Donatos Targets Texas: Pushing Franchise Growth Limits

Updated Category News Views 7

Donatos Pizza: Ambitious Expansion in the Lone Star State When you think about pizza chains expanding, Donatos Pizza might not be the first name to come to mind, but they're cooking up something big in Texas. Folks in Dallas and Houston better be ready because Donatos is rolling out the red carpet for its edge-to-edge, topping-loaded pies all over Texas. Strategic Growth:...

Continue Reading
Guaranteed Roof Expands with EM Exteriors through LB Capital

Updated Category News Views 5

A Bold Move to Elevate Roofing Standards In a move that seems to jolt the roofing industry awake, Guaranteed Roof is taking the wraps off its new strategic partnership with LB Capital and EM Exteriors. Think of it as a power trio aiming to redefine what roofing solutions should mean in the Southeast. It’s the kind of news that makes you sit up and ask, why now and why...

Continue Reading
American Savings Bank Surges 6% on NYSE Debut

Updated Category News Views 6

American Savings Bank Lands with a Bang on NYSE Who would have thought American Savings Bank's (NYSE: ASBH) entry onto the stock market would start with such gusto? It's not every day you see a debut that impressive, with shares soaring 6.25% right out of the gate. Guess it's safe to say the folks over at ASBH did something right in the lead-up to their NYSE launch. CEO...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Partnership Aims to Protect Agritech Workers from Heat Stress

Updated Category News Views 183

Epicore Biosystems Partners with REUS Cares In a significant advancement for worker safety, Epicore Biosystems is teaming up with REUS Cares to introduce an innovative solution designed to combat heat stress for agritech laborers. The new Connected Hydration Armband represents a leap forward in wellness technology, particularly for those working in demanding environments....

Continue Reading
AstraZeneca Seeks EU Approval for Groundbreaking Treatments

Updated Category News Views 317

AstraZeneca's Recent Breakthroughs in the EU AstraZeneca Plc (NASDAQ: AZN) has made significant strides in advancing healthcare through the recent recommendation for approval of two innovative drugs, Tezspire and Koselugo, in the European Union (EU). These developments mark a crucial step towards improving treatment options for patients suffering from chronic conditions....

Continue Reading
Bristow Group Set to Release Vital Q2 2025 Financial Results

Updated Category News Views 133

Bristow Group Announces Upcoming Second Quarter Financial Results Bristow Group Inc. (NYSE: VTOL), a frontrunner in sustainable and innovative vertical flight solutions, is gearing up to release its financial results for the second quarter of 2025. This announcement comes as the company continues its commitment to transparency and openness with its investors. Details of...

Continue Reading
PayPoint plc's Recent Share Transactions Overview

Updated Category News Views 70

PayPoint plc share buyback: recent activity at a glance PayPoint plc has repurchased ordinary shares as part of its ongoing capital management plans. In total, the company bought back 12,545 ordinary shares at a range of prices, reinforcing its focus on delivering value for shareholders and maintaining a disciplined approach to the balance sheet. Transaction specifics On...

Continue Reading
Projected Growth of Medical Sensors Market to Reach $4.48B

Updated Category News Views 127

Insights Into the Thriving Medical Sensors Market The medical sensors market is on track for remarkable growth, with projections estimating its value to reach US$4.48 billion by the year 2030. This impressive advancement, following a compound annual growth rate (CAGR) of 7.9% from 2025 onward, underscores an escalating demand driven by innovation in healthcare...

Continue Reading